Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries

/PRNewswire/ -- Mabwell Bioscience (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, today announced the company...

Related Keywords

China ,Moscow ,Moskva ,Russia ,Shanghai ,Russian ,Datao Liu ,Mabwell Taizhou ,Mabwell Bioscience ,Rustem Muratov ,Significant New Drugs Development ,Binnopharm Group ,Eurasian Economic Union ,China National Medical Products Administration ,National Key Rd Programmes ,Board Of Directors Binnopharm Group ,Mabwell Shanghai Bioscience Co Ltd ,Major Scientific ,Technological Special Project ,Significant New Drug Development ,Twelfth Five Year Plan ,New Drugs ,Mabwell ,